Why is Panacea Biotec falling/rising?

As of 06-Aug, Panacea Biotec Ltd's stock price is currently at Rs 404.00, reflecting a decrease of Rs 17.55 or 4.16%. The stock has underperformed its sector by 2.1% today and has experienced a trend reversal, falling after two consecutive days of gains. It touched an intraday low of Rs 402, indicating a decline of 4.64%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 2.18%, and year-to-date, it has declined by 2.58%, contrasting with a 3.08% increase in the benchmark Sensex.
In the broader market context, the pharmaceuticals and drugs sector has also seen a decline of 2.17%, which may be contributing to the downward pressure on Panacea Biotec's stock. While the stock has shown impressive long-term returns, such as a 202.28% increase over the past year, its recent performance has been lackluster compared to the benchmark, particularly in the short term. The stock's liquidity remains adequate, with a delivery volume increase of 11.23% against the 5-day average, suggesting some investor interest despite the current price drop.